Reducing time to market with AI Powered Automation

According to Deloitte, the average cost of new drug development across the top 20 global biopharma companies reached $2.3 billion in 2022. The slow, painstaking process can take over a decade and require the analysis of over 10,000 molecules to bring a single drug to market.

What strategies are life sciences organizations using to reduce costs and accelerate time to market?In this webinar, UiPath Life Sciences Industry Director Joe Miles and CGI Life Sciences Industry Practice Vice President Michael Schafer will explore how life sciences companies can leverage AI-powered automation to:

• Orchestrate clinical data
• Simplify and accelerate the processing of regulatory submissions
• Eliminate manual or paper-based processes to reduce time to market for new drugs and devices
• Speed and simplify the implementation of solutions like Veeva Vault, SAP, and others used across the R&D landscape

UiPath has worked with life sciences companies for almost two decades and is actively co-innovating with partners like CGI to develop new solution accelerators. Join us for an insightful and interactive conversation about the potential for AI-powered automation to transform your life sciences organization.

About Michael
Mike Shafer is a Vice President leading the Life Sciences Industry Practice at CGI. He is dedicated to helping clients in the Health and Life Sciences sectors improve their methods and better leverage human capital to produce the highest quality, most innovative products for public health at the lowest possible cost.

A former Navy Nuclear Power officer, Mike has held middle and senior level management roles in biological product manufacturing, quality assurance and regulatory compliance, facility start-up and pre-approval inspection, as well as aseptic filling operations and cold chain distribution.